Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Synthesis and Anti-Tuberculosis Activity of Olivacine and Oxygenated Derivatives

Version 1 : Received: 30 April 2018 / Approved: 2 May 2018 / Online: 2 May 2018 (12:54:38 CEST)
Version 2 : Received: 31 May 2018 / Approved: 1 June 2018 / Online: 1 June 2018 (09:39:56 CEST)

A peer-reviewed article of this Preprint also exists.

Schmidt, U.; Theumer, G.; Jäger, A.; Kataeva, O.; Wan, B.; Franzblau, S.G.; Knölker, H.-J. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Molecules 2018, 23, 1402. Schmidt, U.; Theumer, G.; Jäger, A.; Kataeva, O.; Wan, B.; Franzblau, S.G.; Knölker, H.-J. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Molecules 2018, 23, 1402.

Abstract

The tetracyclic pyrido[4,3-b]carbazole olivacine and four of its oxygenated derivatives have been synthesized by a late-stage palladium-catalyzed Heck-type cyclization of the pyrrole ring as key step. In a test for inhibition of the growth of Mycobacterium tuberculosis 9-methoxyolivacine showed the most significant anti-TB activity with an MIC90 value of 1.5 μM.

Keywords

anti-TB activity; catalysis; cyclization; olivacine; palladium; pyrido[4,3-b]carbazoles

Subject

Chemistry and Materials Science, Organic Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.